Lycera Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lycera Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10854
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lycera Corp (Lycera) is a biopharmaceutical company that focuses on the development of oral immune modulators for the treatment of patients with autoimmune diseases and cancer. The company’s pipeline products include LYC-55716, an oral retinoic acid-related orphan receptor gamma (RORgamma) agonist which is in Phase 1/2a ARGON trial that modulates gene expression to reprogram immune cells for improved function and decrease immunosuppressive mechanisms. It also develops novel ATPase modulators for the treatment of autoimmune diseases; and immuno-oncology targets. Lycera is headquartered in Ann Arbor, Michigan, the US.

Lycera Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lycera Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lycera Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lycera Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lycera Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lycera Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lycera Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Lycera Raises US$4 Million In Venture Financing 10
Lycera Raises Additional US$21 Million In Venture Financing 11
Partnerships 12
Lycera Enters into Co-Development Agreement with Celgene 12
Lycera Enters Into Research Agreement With Merck To Develop Novel Treatments For Autoimmune Diseases 13
Licensing Agreements 14
Celgene Exercises Option for Licensing Agreement with Lycera 14
Lycera Corp – Key Competitors 15
Lycera Corp – Key Employees 16
Lycera Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Mar 13, 2017: Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors 18
Product News 19
May 16, 2018: Lycera Announces Publication of Preclinical Immuno-Oncology Research, Demonstrating that Treatment with RORgamma Agonists 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Lycera Corp, Pharmaceuticals & Healthcare, Key Facts 2
Lycera Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lycera Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lycera Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lycera Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Lycera Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lycera Raises US$4 Million In Venture Financing 10
Lycera Raises Additional US$21 Million In Venture Financing 11
Lycera Enters into Co-Development Agreement with Celgene 12
Lycera Enters Into Research Agreement With Merck To Develop Novel Treatments For Autoimmune Diseases 13
Celgene Exercises Option for Licensing Agreement with Lycera 14
Lycera Corp, Key Competitors 15
Lycera Corp, Key Employees 16
Lycera Corp, Other Locations 17

List of Figures
Lycera Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lycera Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lycera Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lycera Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lycera Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lycera Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lycera Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lycera Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Lycera Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Yujin Robot Co Ltdの企業概要及び財務/SWOT分析
    Yujin Robot Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly fo …
  • MaaT Pharma-製薬・医療分野:企業M&A・提携分析
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company is working on two projects, which are in the developmental stage, namely, MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovati …
  • Tata Global Beverages Limited:企業のM&A・事業提携・投資動向
    Tata Global Beverages Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tata Global Beverages Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • AtCor Medical Holdings Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' AtCor Medical Holdings Limited …
  • 4iG Nyrt (4IG):企業概要、財務及び戦略的SWOT分析
    Summary 4iG Nyrt (4iG), formerly Freesoft Szoftverfejleszto & Szolg. Nyrt, is a software company. The company develops and offers software applications. It provides services such as software development, consultation, outsourcing, ASP, hosting and other IT services. The company partners with FreeSof …
  • Kopin Corporation (KOPN):企業の財務及び戦略的SWOT分析
    Summary Kopin Corporation (Kopin) is a technology company that develops and offers new wearable technology and solutions for wearable headset products. The company provides technologies in the areas of ultra-small displays, optics, speech enhancement technology, software, low-power ASICs, and headse …
  • Trustpower Limited:企業の戦略的SWOT分析
    Trustpower Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Lee Enterprises, Inc. (LEE):企業の財務・戦略的SWOT分析
    Lee Enterprises, Inc. (LEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • PetroVietnam:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PetroVietnam Mergers and Acquis …
  • Autoliv, Inc.:企業の戦略・SWOT・財務情報
    Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report Summary Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Unilever Ghana Ltd.:企業の戦略・SWOT・財務情報
    Unilever Ghana Ltd. - Strategy, SWOT and Corporate Finance Report Summary Unilever Ghana Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hydro Ottawa Holding Inc:企業の戦略的SWOT分析
    Hydro Ottawa Holding Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Hoegh LNG Holdings Ltd. (HLNG):企業のM&A・提携動向(石油・ガス分野)
    Summary Hoegh LNG Holdings Ltd. (Hoegh LNG) formerly Leif Hoegh & Co. Limited. is an oil and gas company that offers floating energy solutions. The company provides floating LNG energy services through its floating storage and regasification units. It offers LNG regasification and transportation ser …
  • IndigoVision Group plc (IND):企業の財務及び戦略的SWOT分析
    Summary IndigoVision Group plc (IndigoVision) is a security system manufacturer that develops, manufactures and markets end-to-end IP security management systems. The company’s products include management software, cameras and encoders, specialized cameras and recorders. IndigoVision’s specialized c …
  • Henkel AG & Co. KGaA:企業のM&A・事業提携・投資動向
    Henkel AG & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Henkel AG & Co. KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Rapid Pathogen Screening, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Rapid Pathogen Screening, Inc. (Rapid Pathogen) is a biotechnology company. The company is a developer, and marketer of rapid, point-of-care (POC) diagnostic tests. It uses its patented Direct Sampling Micro-Filtration (DSMF) and Direct Multi-Planar Chromafiltography (DMC) technology. Rapid …
  • Varex Imaging Corp (VREX):企業の財務・戦略的SWOT分析
    Varex Imaging Corp (VREX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hargreaves Services plc:企業の戦略・SWOT・財務分析
    SummaryHargreaves Services plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • TGS-NOPEC Geophysical Company ASA (TGS):石油・ガス:M&Aディール及び事業提携情報
    Summary TGS-NOPEC Geophysical Company ASA (TGS) is a provider of exploration services. It offers multi-client geosciences data to oil and gas exploration and production companies. The company offers a range of global geophysical and geological data libraries including multi-client seismic data, magn …
  • Bass Strait Oil Company Limited (BAS):企業のM&A・提携動向(石油・ガス分野)
    Summary Bass Strait Oil Company Limited (BAS) is an oil and gas company that explores petroleum products. The company operates through the exploration sector of oil and natural gas in onshore and offshore areas of south eastern Australia. Its exploration permit portfolio targets both conventional oi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆